Veterans with ALS Reporting Act

This section mandates that the Secretary of Veterans Affairs, in collaboration with the Director of the Centers for Disease Control and Prevention, must submit a comprehensive report to Congress within one year of the bill's enactment. The report is required to include an assessment of how frequently ALS occurs and how widespread it is among veterans. It must also describe the current resources and support provided by the CDC and VA to veterans with ALS, identify any shortcomings in these services, and propose strategies to reduce the incidence and prevalence of ALS among veterans. Furthermore, the report needs to outline a pathway for veterans receiving ALS care within VA clinics to participate in VA-sponsored clinical trials and research, and offer legislative recommendations to address related challenges.

This provision mandates that the Secretary of Veterans Affairs must continuously monitor the prevalence of amyotrophic lateral sclerosis among veterans. This tracking will be done by utilizing the existing ALS registry and biorepository maintained by the Centers for Disease Control and Prevention. Additionally, the VA Secretary is required to submit updated reports to Congress every three years, starting three years after the bill's enactment. These subsequent reports will provide current information on ALS prevalence as tracked and update the findings and strategies outlined in the initial report.